Get the Stockscreener App
1.4101
0.70%
-0.0099
Aprea Therapeutics Inc stock is traded at $1.4101, with a volume of 30,474.
It is down -0.70% in the last 24 hours and down -11.87% over the past month.
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.
See More
Previous Close:
$1.42
Open:
$1.41
24h Volume:
30,474
Relative Volume:
0.59
Market Cap:
$8.21M
Revenue:
-
Net Income/Loss:
$-14.29M
P/E Ratio:
-0.3534
EPS:
-3.99
Net Cash Flow:
$-12.27M
1W Performance:
-5.99%
1M Performance:
-11.87%
6M Performance:
-35.61%
1Y Performance:
-50.87%
1-Day Range:
$1.3801
$1.4989
1-Week Range:
$1.37
$1.53
52-Week Range:
$1.37
$5.01
Aprea Therapeutics Inc Stock (APRE) Company Profile
Name
Aprea Therapeutics Inc
Sector
Industry
Phone
215-948-4119
Address
3805 OLD EASTON ROAD, DOYLESTOWN, MA
Compare APRE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
APRE
Aprea Therapeutics Inc
|
1.4101 | 8.27M | 0 | -14.29M | -12.27M | -3.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
379.28 | 96.56B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.78 | 60.08B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.07 | 61.15B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
709.97 | 44.66B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
328.00 | 36.23B | 3.81B | -644.79M | -669.77M | -6.24 |
Aprea Therapeutics Inc Stock (APRE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-28-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Dec-16-20 | Initiated | Berenberg | Buy |
| Sep-29-20 | Resumed | JP Morgan | Neutral |
| Jun-22-20 | Initiated | H.C. Wainwright | Neutral |
| Apr-21-20 | Initiated | Robert W. Baird | Outperform |
| Oct-28-19 | Initiated | JP Morgan | Neutral |
| Oct-28-19 | Initiated | Morgan Stanley | Equal-Weight |
| Oct-28-19 | Initiated | RBC Capital Mkts | Outperform |
View All
Aprea Therapeutics Inc Stock (APRE) Latest News
Can Aprea Therapeutics Inc. rally from current levelsGap Up & Verified Stock Trade Ideas - newser.com
Reversal indicators forming on Aprea Therapeutics Inc. stockJuly 2025 Opening Moves & Short-Term High Return Ideas - newser.com
Live market analysis of Aprea Therapeutics Inc.2025 Sector Review & Stock Portfolio Risk Control - newser.com
Using portfolio simulators with Aprea Therapeutics Inc. includedJuly 2025 Trends & Weekly Market Pulse Alerts - newser.com
Historical volatility pattern of Aprea Therapeutics Inc. visualizedJuly 2025 Weekly Recap & Verified Momentum Stock Ideas - newser.com
How to integrate Aprea Therapeutics Inc. into portfolio analysis toolsWeekly Loss Report & Risk Managed Investment Strategies - newser.com
How sentiment analysis helps forecast Aprea Therapeutics Inc.2025 Technical Overview & Risk Adjusted Buy/Sell Alerts - newser.com
Reviewing Aprea Therapeutics (NASDAQ:APRE) and Ventyx Biosciences (NASDAQ:VTYX) - Defense World
Understanding Aprea Therapeutics Inc.’s price movement2025 Major Catalysts & Real-Time Price Movement Reports - newser.com
What MACD and RSI say about Aprea Therapeutics Inc.Portfolio Update Report & Daily Profit Focused Stock Screening - newser.com
Aprea Therapeutics Advances ACESOT-1051 Clinical Trial with Key Patient Dosing - MSN
Price momentum metrics for Aprea Therapeutics Inc. explainedJuly 2025 Spike Watch & Verified Swing Trading Watchlist - newser.com
Aug Drivers: Should I set a stop loss on Aprea Therapeutics IncJuly 2025 Sentiment & Precise Swing Trade Alerts - خودرو بانک
How institutional ownership impacts Aprea Therapeutics Inc. stockJuly 2025 Catalysts & Weekly Breakout Stock Alerts - newser.com
Aug Intraday: Is Aprea Therapeutics Inc gaining market sharePortfolio Return Report & Reliable Entry Point Alerts - khodrobank.com
Market Catalysts: What drives Aprea Therapeutics Incs stock price2025 Volume Leaders & High Yield Equity Trading Tips - خودرو بانک
Can Aprea Therapeutics Inc. recover in the next quarterQuarterly Profit Report & AI Powered Market Trend Analysis - newser.com
Loss Report: Is Ming Shing Group Holdings Limited stock a good pick for beginners2025 Winners & Losers & Verified Momentum Stock Alerts - خودرو بانک
Market Catalysts: Is Aprea Therapeutics Inc stock technically oversoldJuly 2025 Price Swings & Detailed Earnings Play Strategies - خودرو بانک
Earnings Risk: Is SABS stock risky to hold nowAnalyst Upgrade & Step-by-Step Trade Execution Guides - خودرو بانک
Buyout Rumor: Whats the beta of Repligen Corporation stockCPI Data & Weekly High Momentum Picks - خودرو بانک
Bond Watch: Is ProShares Trust ProShares Short FTSE China 50 stock trending bullishJuly 2025 Levels & Verified Momentum Stock Watchlist - خودرو بانک
Risk adjusted return profile for Aprea Therapeutics Inc. analyzed2025 Support & Resistance & Fast Entry Momentum Trade Alerts - newser.com
Published on: 2025-09-16 14:38:02 - خودرو بانک
Aprea Therapeutics, Inc. (NASDAQ:APRE) Short Interest Up 42.5% in August - Defense World
Tools to monitor Aprea Therapeutics Inc. recovery probabilityWeekly Market Summary & Fast Momentum Stock Entry Tips - newser.com
Bull Bear: Will Aprea Therapeutics Inc stock go up in YEARLong Setup & Daily Growth Stock Investment Tips - خودرو بانک
Aug Analyst Calls: Can Aprea Therapeutics Inc outperform under higher oil pricesWeekly Stock Summary & Stepwise Entry/Exit Trade Alerts - خودرو بانک
Whale Trades: Will Aprea Therapeutics Inc benefit from AI trends2025 AllTime Highs & Growth Focused Entry Point Reports - خودرو بانک
Aug Sentiment: Is Pliant Therapeutics Inc still a buy after recent gains2025 Market Trends & Fast Gaining Stock Strategy Reports - خودرو بانک
Aug Mood: What is Aprea Therapeutics Inc. s revenue forecastJuly 2025 Analyst Calls & Stepwise Entry and Exit Trade Signals - خودرو بانک
Portfolio Shifts: Does BlueLinx Holdings Inc. stock reflect fundamentals - خودرو بانک
Market Review: Is Aprea Therapeutics Inc backed by strong institutional buying2025 Investor Takeaways & Weekly Watchlist for Consistent Profits - خودرو بانک
Aug Highlights: Will Aprea Therapeutics Inc. benefit from geopolitical trendsMarket Sentiment Review & Detailed Earnings Play Strategies - خودرو بانک
Panic Selling: Is Aprea Therapeutics Inc stock a buy or sell2025 Buyback Activity & AI Powered Market Entry Ideas - خودرو بانک
Guidance Update: Is Aprea Therapeutics Inc. stock influenced by commodity prices2025 Institutional Moves & Technical Pattern Recognition Alerts - خودرو بانک
Aprea Therapeutics Inc Stock (APRE) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):